Literature DB >> 16053881

Response of diffuse sclerosing osteomyelitis of the mandible to alendronate: follow-up study by 99mTc scintigraphy.

S Hino1, R Murase, N Terakado, S Shintani, H Hamakawa.   

Abstract

We report a case of diffuse sclerosing osteomyelitis of the mandible responded to alendronate, after a poor response to intravenous antibiotics, antibiotic irrigation-perfusion, and decortication. The patient was given an intravenous infusion of 10mg of alendronate. Pain resolved within 24 h. There were no severe adverse events. Increased uptake of 99mTc in the mandible almost completely disappeared 3 months after treatment.

Entities:  

Mesh：

Substances：

Year:  2005        PMID： 16053881     DOI： 10.1016/j.ijom.2005.01.003

Source DB:  PubMed          Journal:  Int J Oral Maxillofac Surg        ISSN： 0901-5027            Impact factor:   2.789


  4 in total

1.  Localized osteomyelitis of the mandible secondary to dental treatment: report of a case.

Authors:  Saeed Nezafati; Mohammad Ali Ghavimi; Amir Saeed Yavari
Journal:  J Dent Res Dent Clin Dent Prospects       Date:  2009-06-05

Review 2.  Beyond ONJ - A review of the potential uses of bisphosphonates in dentistry.

Authors:  N P Shah; S Nayee; M Pazianas; C Sproat
Journal:  Br Dent J       Date:  2017-05-12       Impact factor: 1.626

3.  [Importance of SPECT/CT for resolving diseases of the jaw].

Authors:  K Strobel; M Merwald; M W Huellner; C Bolouri; P Veit-Haibach; M del Sol Pèrez-Lago; J Kuttenberger
Journal:  Radiologe       Date:  2012-07       Impact factor: 0.635

4.  Imaging findings of bisphosphonate-associated osteonecrosis of the jaws.

Authors:  P M Phal; R W T Myall; L A Assael; J L Weissman
Journal:  AJNR Am J Neuroradiol       Date:  2007 Jun-Jul       Impact factor: 3.825
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.